Canadian Cardiovascular Society/Canadian Association of Interventional Cardiology 2023 Focused Update of the Guidelines for the Use of Antiplatelet Therapy-Reference-Cited by-同舟云学术

Canadian Cardiovascular Society/Canadian Association of Interventional Cardiology 2023 Focused Update of the Guidelines for the Use of Antiplatelet Therapy

Published:2023-10 Issue: Volume: Page:
ISSN:0828-282X
Container-title:Canadian Journal of Cardiology
language:en
Short-container-title:Canadian Journal of Cardiology

Author:

Bainey Kevin R.^ORCID,Marquis-Gravel Guillaume,Belley-Côté Emilie,Turgeon Ricky D.,Ackman Margaret L.,Babadagli Hazal E.,Bewick David,Boivin-Proulx Laurie-Anne,Cantor Warren J.,Fremes Stephen E.,Graham Michelle M.,Lordkipanidzé Marie,Madan Mina,Mansour Samer,Mehta Shamir R.,Potter Brian J.,Shavadia Jay,So Derek F.,Tanguay Jean-François,Welsh Robert C.,Yan Andrew T.,Bagai Akshay,Bagur Rodrigo,Bucci Claudia,Elbarouni Basem,Geller Carol,Lavoie Andrea,Lawler Patrick,Liu Shuangbo,Mancini John,Wong Graham C.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference85 articles.

1. The use of antiplatelet therapy in the outpatient setting: Canadian Cardiovascular Society guidelines;Bell;Can J Cardiol,2011

2. Focused 2012 update of the Canadian Cardiovascular Society guidelines for the use of antiplatelet therapy;Tanguay;Can J Cardiol,2013

3. 2018 Canadian Cardiovascular Society/Canadian Association of Interventional Cardiology focused update of the guidelines for the use of antiplatelet therapy;Mehta;Can J Cardiol,2018

4. Effect of aspirin on disability-free survival in the healthy elderly;McNeil;N Engl J Med,2018

5. Effects of aspirin for primary prevention in persons with diabetes mellitus;Bowman;N Engl J Med,2018

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chez les patients présentant un syndrome coronarien aigu et ayant subi une intervention coronarienne percutanée avec des endoprothèses contemporaines et qui n’ont pas eu d’événement ischémique ou hémorragique pendant 1 mois sous traitement antiplaquettaire double, est-ce qu’un traitement par ticagrélor seul entre le 1er et le 12e mois diminue le risque de saignement cliniquement important tout en étant efficace pour prévenir les complications vasculaires comparativement au ticagrélor combiné à l’aspirine ?;La Revue de Médecine Interne;2024-08

2. Is there a role for pre-hospital administration of potent antiplatelet therapy in ST-segment elevation myocardial infarction?;European Heart Journal: Acute Cardiovascular Care;2024-07-24

3. Erratum to “Canadian Cardiovascular Society/Canadian Association of Interventional Cardiology 2023 Focused Update of the Guidelines for the Use of Antiplatelet Therapy” [Can J Cardiol 40 (2024):160-181].;Canadian Journal of Cardiology;2024-07

4. Research and scholarly methods: Appraising the available literature to inform a research project;JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY;2024-06-19

5. Evidence-based expert consensus on clinical management of safety of Bruton's tyrosine kinase inhibitors (2024);CHINESE J CANCER RES;2024